Ahmad Riad Ramadan is a vascular neurologist and neurointensivist at the Henry Ford Neuroscience Institute, Henry Ford Hospital, Detroit, MI, USA. He also is the program director for the Neurocritical Care Fellowship and chairs the Scientific Advisory Board of the Department of Neurology. Gamaleldin Osman is at the Mayo Clinic Comprehensive Epilepsy Center, Neurology Department, in Rochester, Minnesota.

Select Guide Rating

• 1. Fears and hopes2. Neuropathogenesis of SARS-CoV-2 infection3. Neurological presentations of COVID-194. COVID-19 and cerebrovascular diseases5. COVID-19 and seizures6. COVID-19 and autoimmune demyelinating diseases 7. COVID-19 and neuromuscular disorders8. Pediatric neurology and the COVID-19 pandemic9. Neuro-oncologic care during the COVID-19 pandemic10. COVID-19 infection: Impaired olfaction, movement disorders, encephalopathy, and neuropsychiatric manifestations11. COVID-19 and headache disorders12. Treatment approach, pharmacological agents and vaccines 13. Response of healthcare systems to the pandemicAppendix: Medications

Ahmad Riad Ramadan is a vascular neurologist and neurointensivist at the Henry Ford Neuroscience Institute, Henry Ford Hospital, Detroit, MI, USA. He also is the program director for the Neurocritical Care Fellowship and chairs the Scientific Advisory Board of the Department of Neurology. Gamaleldin Osman is at the Mayo Clinic Comprehensive Epilepsy Center, Neurology Department, in Rochester, Minnesota.

Select Guide Rating

• 1. Fears and hopes2. Neuropathogenesis of SARS-CoV-2 infection3. Neurological presentations of COVID-194. COVID-19 and cerebrovascular diseases5. COVID-19 and seizures6. COVID-19 and autoimmune demyelinating diseases 7. COVID-19 and neuromuscular disorders8. Pediatric neurology and the COVID-19 pandemic9. Neuro-oncologic care during the COVID-19 pandemic10. COVID-19 infection: Impaired olfaction, movement disorders, encephalopathy, and neuropsychiatric manifestations11. COVID-19 and headache disorders12. Treatment approach, pharmacological agents and vaccines 13. Response of healthcare systems to the pandemicAppendix: Medications

Ahmad Riad Ramadan is a vascular neurologist and neurointensivist at the Henry Ford Neuroscience Institute, Henry Ford Hospital, Detroit, MI, USA. He also is the program director for the Neurocritical Care Fellowship and chairs the Scientific Advisory Board of the Department of Neurology. Gamaleldin Osman is at the Mayo Clinic Comprehensive Epilepsy Center, Neurology Department, in Rochester, Minnesota.

Select Guide Rating

• 1. Fears and hopes2. Neuropathogenesis of SARS-CoV-2 infection3. Neurological presentations of COVID-194. COVID-19 and cerebrovascular diseases5. COVID-19 and seizures6. COVID-19 and autoimmune demyelinating diseases 7. COVID-19 and neuromuscular disorders8. Pediatric neurology and the COVID-19 pandemic9. Neuro-oncologic care during the COVID-19 pandemic10. COVID-19 infection: Impaired olfaction, movement disorders, encephalopathy, and neuropsychiatric manifestations11. COVID-19 and headache disorders12. Treatment approach, pharmacological agents and vaccines 13. Response of healthcare systems to the pandemicAppendix: Medications